Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-b enzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo

Publication Date

7-20-2020

DOI

10.1208/S12248-020-00472-X

ISSN

1550-7416

PubMed ID

32691179

Share

COinS